Back to 
BAKER BROS. ADVISORS LP
BAKER BROS. ADVISORS LP
PTGX
Showing 0 of 11 quarters
Position history for BAKER BROS. ADVISORS LP's holdings in PROTAGONIST THERAPEUTICS INC
No. Baker Bros. Advisors exited its PTGX (Protagonist Therapeutics) position in Q3 2021. Its Q2 2021 13F listed 455,276 shares worth $20.4M. Baker Bros. Advisors already held PTGX in its Q1 2019 13F, the earliest on record, and held it in 10 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.